Aligns with Company’s strategic focus on bringing to market state-of-the-art advanced disinfection systems
The demand for effective disinfection methods in healthcare environments, particularly operating rooms, has never been more critical. Traditional chemical-based approaches often fall short in terms of safety, effectiveness, and ease of use, especially in occupied spaces. Additionally, the risk of pathogen transmission in these critical areas necessitates innovative solutions to ensure a sterile environment not only during surgical procedures but also in the intervals between them.
The cornerstone of this novel system is the PURONet Control System, which represents a seamless integration of the best elements of continuous and terminal disinfection methods. The PURONet Control System serves as the central nervous system, seamlessly interfacing with the Puro Protect 222 system for safe, continuous disinfection during occupancy, and the Helo LED system for deep, terminal disinfection when spaces are unoccupied.
This dual approach marries the necessity of continuous low-level disinfection with the thoroughness of terminal cleaning cycles, ensuring optimal safety and efficiency. The Puro Protect 222 system operates discreetly in the background, providing non-invasive disinfection while rooms are in use, thus ensuring operations can continue without interruption. Once vacated, the Helo LED system takes over, employing a powerful spectrum of UV light to thoroughly disinfect the environment, preparing it for the next use.
By integrating these two disinfection states, the PURONet Control System not only optimizes energy use but also extends the life cycle of the fixtures while enhancing the safety of patients and staff through its intelligent, adaptive control. This integrated approach underscores Applied UV’s strategic focus on delivering innovative, energy-efficient, and effective disinfection solutions that meet the rigorous demands of modern healthcare environments.
Today, the Company’s SteriLumen subsidiary has provided its disinfections systems to such renowned hospitals as University of Chicago Medical Center,
PURO Protect 222 Troffer Innovation and Benefits:
- Safety in Occupied Spaces: The Puro Protect 222 system allows for continuous disinfection without evacuating the room, making it ideal for high-traffic healthcare environments.
- Effective Terminal Disinfection: The Helo LED system provides a robust solution for deep disinfection of unoccupied spaces, targeting a broad range of pathogens.
- Optimized Control: The PURONet Control System intelligently manages the operation of both systems, ensuring that disinfection processes are optimized for safety, energy efficiency, and efficacy based on real-time occupancy data.
- Design Flexibility: The integrated fixtures are designed for versatile installation, fitting seamlessly into existing healthcare infrastructure with minimal disruption.
- Comprehensive Disinfection: By combining different wavelengths of light controlled through an intelligent system, this invention provides a layered approach to disinfection, significantly reducing the risk of pathogen transmission.
“We continue to build a robust intellectual property (“IP”) portfolio that supports our strategic focus of providing our healthcare customers innovative, energy efficient and cost-effective air disinfection systems,” stated
About PURO UV Disinfection Lighting
PURO UV Disinfection Lighting promotes health and safety by bringing proven and powerful UV light disinfection devices to all indoor spaces where people gather including hospitals, schools and universities, medical and manufacturing facilities, transportation, office buildings, and much more, all without the use of chemicals. From HVAC systems to in room and upper air disinfection, PURO Lighting products offer a wide variety of UV technologies to provide continuous disinfection of air in occupied spaces and can rapidly disinfect any indoor area inactivating viruses, bacteria, fungi and more including SARS-CoV-2 virus.
About Applied UV
Forward-Looking Statements
The information contained herein may contain “forward-looking statements.” Forward-looking statements reflect the current view about future events. When used in this press release, the words “anticipate,” “believe,” “estimate,” “expect,” “future,” “intend,” “plan,” or the negative of these terms and similar expressions, as they relate to us or our management, identify forward-looking statements. Such statements include, but are not limited to, statements contained in this press release relating to its business strategy. Forward-looking statements are based on the Company’s current expectations and assumptions regarding its business, the economy and other future conditions. Because forward–looking statements relate to the future, they are subject to inherent uncertainties, risks and changes in circumstances that are difficult to predict. The Company’s actual results may differ materially from those contemplated by the forward-looking statements. They are neither statements of historical fact nor guarantees of assurance of future performance. We caution you therefore against relying on any of these forward-looking statements. Factors or events that could cause the Company’s actual results to differ may emerge from time to time, and it is not possible for the Company to predict all of them. These forward-looking statements and factors that may cause such differences include, without limitation, the risks disclosed in the Company’s Annual Report on Form 10-K filed with the
For Additional Company Information:
Applied UV Founder, CEO & Director
Max.munn@applieduvinc.com
Investor Relations Contact:
TraDigital IR
+1-646-418-7002
kevin@tradigitalir.com
Attachment
Applied UV, Inc.
Applied UV, Inc.
PURONet, Surgical Level of Disinfection
2024 GlobeNewswire, Inc., source